972 episodes

Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.

Research To Practice | Oncology Videos Research To Practice

    • Science
    • 4.6 • 75 Ratings

Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.

    • video
    Multiple Myeloma | Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 2

    Multiple Myeloma | Meet The Professor: Optimizing the Management of Multiple Myeloma — Part 2

    Featuring perspectives from Dr Paul Richardson, including the following topics:
    Introduction (0:00) Case: A man in his early 60s with newly diagnosed Stage II standard-risk multiple myeloma — Ranju Gupta, MD (29:31) Case: A woman in her early 70s with Stage IIIA multiple myeloma who receives lenalidomide/bortezomib/dexamethasone → autologous stem cell transplant (ASCT) and discontinues maintenance lenalidomide after 3 years — Erik Rupard, MD (34:16) Case: A woman in her early 70s with relapsed myeloma after tandem ASCT who receives cyclophosphamide/bortezomib/dexamethasone, achieves minimum residual disease negativity and is now on maintenance ixazomib — Zanetta S Lamar, MD (39:01) Case: A woman in her early 70s with triple-class refractory t(11;14) multiple myeloma — Hans Lee, MD (43:47) Case: A man in his mid 60s with high-risk relapsed multiple myeloma after carfilzomib/lenalidomide/dexamethasone (KRd) induction, ASCT, maintenance KRd and 2 additional lines of therapy — Muzaffar H Qazilbash, MD (46:05) Faculty Survey (52:29) Journal Club with Dr Richardson (60:57) CME information and select publications

    • 1 hr 4 min
    • video
    Myelofibrosis | Oncology Today with Dr Neil Love: Novel Agents and Strategies in Myelofibrosis (Companion Faculty Lecture)

    Myelofibrosis | Oncology Today with Dr Neil Love: Novel Agents and Strategies in Myelofibrosis (Companion Faculty Lecture)

    Featuring a slide presentation and related discussion from Dr Ruben Mesa, including the following topics:
    Efficacy and safety of FDA-approved JAK inhibitors for the management of myelofibrosis (MF) (0:00) Emerging JAK inhibitors under Phase III evaluation for MF (6:59) Current guidelines and strategies for managing MF (13:53) Emerging data with novel agents and strategies for MF (17:31) Splenic response and symptomology in patients with MF (25:36) CME information and select publications

    • 32 min
    • video
    Myelofibrosis | Oncology Today with Dr Neil Love: Novel Agents and Strategies in Myelofibrosis

    Myelofibrosis | Oncology Today with Dr Neil Love: Novel Agents and Strategies in Myelofibrosis

    Featuring an interview with Dr Ruben Mesa, including the following topics:
    Managing myelofibrosis (MF) before the availability of ruxolitinib (0:00) Pathobiology and mutational profile of MF (7:33) Matching treatments to individual patients with MF (13:25) Case: A man in his early 70s with MF and worsening anemia (17:13) Case: A man in his late 60s initially diagnosed with polycythemia vera now with MF requiring therapy (23:15) Case: A woman in her mid 60s with MF that has a suboptimal response to first-line JAK inhibitor therapy (30:25) Efficacy and safety of novel agents and strategies for MF (35:40) CME information and select publications

    • 41 min
    • video
    Ovarian Cancer | Consensus or Controversy? Current and Future Management of Ovarian Cancer

    Ovarian Cancer | Consensus or Controversy? Current and Future Management of Ovarian Cancer

    Featuring perspectives from Drs Ursula Matulonis and Debra Richardson, including the following topics:
    PROLOGUE: Antibody-Drug Conjugates Across Oncology (0:00) Antibody-Drug Conjugates in Ovarian Cancer: Mirvetuximab Soravtansine (10:03) Antibody-Drug Conjugates in Ovarian Cancer: Upifitamab Rilsodotin (29:09) Tumor Treating Fields (41:35) PARP Inhibitor Update (47:29) CME information and select publications
     

    • 1 hr 3 min
    • video
    Renal Cell Carcinoma | Oncology Today with Dr Neil Love: Management of Renal Cell Carcinoma (Companion Faculty Lecture)

    Renal Cell Carcinoma | Oncology Today with Dr Neil Love: Management of Renal Cell Carcinoma (Companion Faculty Lecture)

    Featuring a slide presentation and related discussion from Dr Toni Choueiri, including the following topics:
    Evolution in the management of renal cell carcinoma (RCC) (0:00) Adjuvant therapy for intermediate- or high-risk RCC (1:52) Front-line therapy for patients with metastatic RCC (8:39) New agents for the treatment of relapsed or refractory RCC (16:24) Mechanism of action and efficacy of HIF2-alpha inhibitors for von Hippel-Lindau-associated RCC (19:56) CME information and select publications

    • 26 min
    • video
    Renal Cell Carcinoma | Oncology Today with Dr Neil Love: Management of Renal Cell Carcinoma

    Renal Cell Carcinoma | Oncology Today with Dr Neil Love: Management of Renal Cell Carcinoma

    Featuring an interview with Dr Toni Choueiri, including the following topics:
    Case: A woman in her early 70s with a large kidney tumor and multiple pulmonary nodules (0:00) Case: A woman in her early 60s diagnosed with metastatic clear cell renal cell carcinoma (RCC) (12:52) Approach to adjuvant treatment for RCC (16:14) Examining differences between PD-1 and PD-L1 inhibitors (20:09) Management of non-clear cell RCC (24:10) Challenges in identifying patients with RCC who are more likely to benefit from immune checkpoint inhibitors (28:22) Mechanisms of action of HIF2-alpha inhibitors for von Hippel-Lindau-associated RCC (30:31) Future directions in the care of patients with RCC (36:24) CME information and select publications

    • 40 min

Customer Reviews

4.6 out of 5
75 Ratings

75 Ratings

a h/o ,

Valued resource

Relentless in its focus on the general medical oncolgist. An important resource.

obete man ,

Excellent

Since my fellowship training Neil Love has made these presentations the best of the best in staying UpToDate with current and future practice

OKMedStudent ,

RTP is is consistently great

Research to Practice continues to put out well produced clinically relevant content from expert faculty that is applicable to daily oncology practice. It is an invaluable resource for me.

Top Podcasts In Science

Hidden Brain
Alie Ward
Freakonomics Radio + Stitcher
Neil deGrasse Tyson
Sam Harris
Mike Carruthers / OmniCast Media / Cumulus Podcast Network

You Might Also Like

Research To Practice
Dr Neil Love
Dr Neil Love
Vinay Prasad, MD MPH
Dr Neil Love
Dr Neil Love

More by Research To Practice

Dr Neil Love
Dr Neil Love
Dr Neil Love
Dr Neil Love
Dr Neil Love
Dr Neil Love